LIQ861

Liquidia Resubmits New Drug Application for LIQ861 (treprostinil) Inhalation Powder for the Treatment of Pulmonary Arterial Hypertension MORRISVILLE, N.C., May 10, 2021 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA)

Read more